NewGenIvf (NIVF) Interest & Investment Income (2024 - 2025)

NewGenIvf (NIVF) reported Interest & Investment Income of $2003.0 for Q3 2025, down 16.51% year-over-year from $2399.0 in Q3 2024, and up 25.66% quarter-over-quarter from $1594.0 in Q2 2025.

NewGenIvf (NIVF) Interest & Investment Income (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has 2 years of Interest & Investment Income data on file, last reported at $2003.0 in Q3 2025.

  • Interest & Investment Income for Q3 2025 came in at $2003.0, down 16.51% year-over-year; the trailing twelve-month figure through Sep 2025 was $2003.0 (down 16.51% YoY), and the FY2025 annual result was $2251.0, down 67.63% from the prior year.
  • Interest & Investment Income advanced to $2003.0 in Q3 2025 per NIVF's latest filing, from $1594.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $2399.0 in Q3 2024 and troughed at $1594.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn -
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn -
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn -
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn -
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 6.54 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn -81.48 Mn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 890,000.00
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn -
10 NewGenIvf - - 524,025.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 2,003.00
Jun 30, 2025 1,594.00
Sep 30, 2024 2,399.00